HK1204451A1 - Novel use - Google Patents

Novel use

Info

Publication number
HK1204451A1
HK1204451A1 HK15105009.1A HK15105009A HK1204451A1 HK 1204451 A1 HK1204451 A1 HK 1204451A1 HK 15105009 A HK15105009 A HK 15105009A HK 1204451 A1 HK1204451 A1 HK 1204451A1
Authority
HK
Hong Kong
Prior art keywords
novel use
novel
Prior art date
Application number
HK15105009.1A
Other languages
English (en)
Chinese (zh)
Inventor
Georgios Tzortzis
Original Assignee
Clasado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clasado Inc filed Critical Clasado Inc
Publication of HK1204451A1 publication Critical patent/HK1204451A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
HK15105009.1A 2013-03-28 2015-05-26 Novel use HK1204451A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1305708.8A GB201305708D0 (en) 2013-03-28 2013-03-28 Novel use

Publications (1)

Publication Number Publication Date
HK1204451A1 true HK1204451A1 (en) 2015-11-20

Family

ID=48444941

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105009.1A HK1204451A1 (en) 2013-03-28 2015-05-26 Novel use

Country Status (19)

Country Link
US (2) US11241449B2 (fr)
EP (1) EP2978432B1 (fr)
JP (1) JP6309612B2 (fr)
KR (2) KR20210038701A (fr)
CN (1) CN105073120A (fr)
AR (1) AR095738A1 (fr)
AU (1) AU2014242798B2 (fr)
BR (1) BR112015024625A2 (fr)
CA (1) CA2908230C (fr)
ES (1) ES2722852T3 (fr)
GB (2) GB201305708D0 (fr)
HK (1) HK1204451A1 (fr)
IL (1) IL241844B (fr)
MX (1) MX2015013699A (fr)
MY (1) MY175533A (fr)
RU (1) RU2663696C2 (fr)
SG (2) SG10201707152TA (fr)
TW (1) TWI507198B (fr)
WO (1) WO2014155056A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
EP2886140A1 (fr) * 2013-12-17 2015-06-24 University of Limerick Appareil pour le traitement extracorporel du sang
WO2016029113A1 (fr) * 2014-08-22 2016-02-25 Abbott Laboratories Procédés d'augmentation de la production endogène de bêta-hydroxy-bêta-méthylbutyrate
EP3969009A1 (fr) * 2019-05-15 2022-03-23 N.V. Nutricia Bêta-1,3'-galactosyllactose pour le traitement de maladies de la fonction barrière intestinale
CN115089596A (zh) * 2022-06-20 2022-09-23 自然资源部第三海洋研究所 新琼寡糖用于制备治疗抑郁症产品的新用途
GB2623335A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
US20040265279A1 (en) * 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
JP4384656B2 (ja) * 2003-06-30 2009-12-16 クラサド インコーポレイテッド 新規のガラクトシダーゼ酵素活性を生じさせるビフィドバクテリウムビフィダムの新規株
CN101095698B (zh) * 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
ITMI20071214A1 (it) 2007-06-15 2008-12-16 S I I T Srl Servizio Internazi Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale
BRPI0822485A2 (pt) * 2008-03-18 2015-06-16 Aleksander Vladimirovich Dikovskiy Composição farmacêutica para prevenção de disbiose associada com administração enteral de antibióticos.
EP2110028A1 (fr) * 2008-04-15 2009-10-21 Nestec S.A. Expression de BDNF hippocampique et de Bifidobacterium longum
GB0809921D0 (en) 2008-05-30 2008-07-09 Clasado Inc Product and process therefor
EP2405918B2 (fr) 2009-03-13 2020-09-02 The Regents of The University of California Oligosaccharides prébiotiques
BR112012010108A2 (pt) * 2009-10-30 2016-05-31 Prometheus Laboratoires Inc métodos para auxiliar no diagnóstico e para monitorar a progressão ou regressão da síndrome do intestino irritável, meio legível por computador, e, sistema para classificar se uma amostra de soro ou sangue de um indivíduo está associada com a síndrome do intestino irritável
WO2011060123A1 (fr) * 2009-11-12 2011-05-19 Nestec S.A. Composition nutritionnelle permettant de favoriser l'équilibre de microbiotes digestifs et la santé
US20120276208A1 (en) 2011-04-27 2012-11-01 University Of South Australia Acute cognitive and mood effects of plant polysaccharides in adult human subjects

Also Published As

Publication number Publication date
GB2515865A (en) 2015-01-07
US20220143054A1 (en) 2022-05-12
AR095738A1 (es) 2015-11-04
SG10201707152TA (en) 2017-10-30
GB201405503D0 (en) 2014-05-14
KR20210038701A (ko) 2021-04-07
RU2015146305A (ru) 2017-05-04
TW201444562A (zh) 2014-12-01
BR112015024625A2 (pt) 2017-07-18
SG11201507668UA (en) 2015-10-29
CA2908230A1 (fr) 2014-10-02
CN105073120A (zh) 2015-11-18
IL241844B (en) 2018-06-28
US11241449B2 (en) 2022-02-08
US20160045524A1 (en) 2016-02-18
TWI507198B (zh) 2015-11-11
JP2016516743A (ja) 2016-06-09
WO2014155056A1 (fr) 2014-10-02
GB2515865B (en) 2017-05-10
MY175533A (en) 2020-07-01
AU2014242798A1 (en) 2015-10-08
CA2908230C (fr) 2021-04-13
ES2722852T3 (es) 2019-08-19
RU2663696C2 (ru) 2018-08-08
EP2978432B1 (fr) 2019-02-20
EP2978432A1 (fr) 2016-02-03
KR102235730B1 (ko) 2021-04-02
GB201305708D0 (en) 2013-05-15
JP6309612B2 (ja) 2018-04-11
KR20150135504A (ko) 2015-12-02
MX2015013699A (es) 2016-05-31
AU2014242798B2 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
DK3088517T3 (en) Humant anti-il-33-neutraliserende monoklonalt antistof
DK3354246T3 (en) Udstyrsmonteringssystem
DK3077519T3 (en) Cmv-vacciner
RS59816B1 (sr) Nova primena
GB201305825D0 (en) New use
EP2968338A4 (fr) Nouvelles utilisations
EP2956141A4 (fr) Nouvelles utilisations
HK1204451A1 (en) Novel use
AU353576S (en) Stamphousing
DK3056208T3 (en) Immunpotentiator
DK2979701T3 (en) Antitumormiddel indbefattende irinotecanhydrochloridhydrat
DK2989854T3 (en) Strømstyret opvarmningssystem
GB201321223D0 (en) Novel use
GB201321218D0 (en) Novel use
GB201319828D0 (en) Novel use
GB201319824D0 (en) Novel use
GB201318414D0 (en) Novel use
GB201318415D0 (en) Novel use
AU4899P (en) Herbie53 Iresine herbstii
AU4953P (en) Flogazora Gazania rigens
AU4977P (en) Harrosy Gaura lindheimeri
AU353325S (en) Kettlebell
AU353330S (en) Kettlebell
AU353331S (en) Kettlebell
AU353329S (en) Kettlebell

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210329